Rankings
▼
Calendar
CAMP Q3 2019 Earnings — CAMP4 Therapeutics Corporation Revenue & Financial Results | Market Cap Arena
CAMP
CAMP4 Therapeutics Corporation
$126M
Q3 2019 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$93M
-2.9% YoY
Gross Profit
$38M
40.4% margin
Operating Income
-$5M
-4.9% margin
Net Income
-$7M
-7.9% margin
EPS (Diluted)
$-0.22
QoQ Revenue Growth
+4.7%
Cash Flow
Operating Cash Flow
$5M
Free Cash Flow
-$594,000
Stock-Based Comp.
$3M
Balance Sheet
Total Assets
$659M
Total Liabilities
$466M
Stockholders' Equity
$193M
Cash & Equivalents
$194M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$93M
$96M
-2.9%
Gross Profit
$38M
$40M
-5.4%
Operating Income
-$5M
$4M
-208.4%
Net Income
-$7M
-$854,000
-762.9%
Revenue Segments
Product
$62M
67%
Application Subscriptions And Related Products And Service
$31M
33%
Geographic Segments
UNITED STATES
$69M
74%
E M E A
$13M
14%
Latin America
$4M
5%
All Other
$3M
3%
CANADA
$2M
3%
Asia Pacific
$2M
2%
← FY 2019
All Quarters
Q4 2019 →